AbCellera Biologics Inc. (ABCL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.02B |
| Enterprise Value | 1.04B |
| P/E Ratio | -11.96 |
| PEG Ratio | -0.76 |
| Price/Sales Ratio | 22.13 |
| Price/Book Ratio | 1.85 |
| Enterprise/Revenue | 22.93 |
| Enterprise/EBITDA | -11.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.82 |
| Operating Margin | -2.68 |
AD
Management Effectiveness
| Return On Assets | -0.11 |
| Return On Equity | -0.15 |
Income Statement
| Revenue | 75.13M |
| Revenue/Share | 0.26 |
| Gross Profit | 46.31M |
| EBITDA | -148.77M |
| Net Income | -146.41M |
| Diluted EPS | -0.49 |
Balance Sheet
| Total Cash | 504.73M |
| Total Cash/Share | 1.67 |
| Total Debt | 140.18M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 14.05 |
| Book Value Per Share | 3.1 |
Price History
| 52-Week Change | 72.37 |
| 52-Week High | 6.79 |
| 52-Week Low | 2.75 |
| Moving Average 50 Days | 4.82 |
| Moving Average 200 Days | 4.27 |
Statistics
| Average Volume | 6.55M |
| Shares Outstanding | 305.38M |
| % Held by Institutions | 41.61 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
